INTRODUCTION
The detection of malignant renal masses and their differentiation from their benign counterparts is extremely important, especially when these masses are small. Despite recent advances, most renal adenocarcinomas are relatively unresponsive to chemotherapy and radiation therapy. Surgery for higher stage lesions are associated with increased morbidity and mortality. Surgery of low stage lesions when detected and characterised early remains the only hope for long term survival or cure. There are different studies available regarding the evaluation of renal masses, some using the conventional CT and some using the MDCT with advanced techniques. The studies using MDCT for evaluation are less as it is recently developed. Most of the studies are done in other population groups with fewer studies on Indian population. Our study is done on Indian population using MDCT. Cohan RH et al in 1995 reviewed CMP, NP, and combination images. They concluded that CT scans obtained only during the CMP of contrast enhancement fail to depict many renal masses that are easily seen on NP images 1 . A R Joshi et al (2004) in their study found that Multidetector spiral CT proved to be an excellent modality for the detection, localization and quantification of renal arterial stenosis, neovascularity and feeding vessels of renal malignancies, with the ability to view the data set in all three dimensions, as opposed to angiography this constitutes an added advantage . When compared to conventional axial CT MDCT has an additional advantage of rapid and continuous scanning which allows an entire sequence to be obtained during a single breath hold to reduce the motion artefacts and scan delay. It is also possible to acquire images with narrow collimation to reduce partial volume averaging. Excellent images can be acquired with multiplanar reconstruction, volume reformatting, MIP and MinIP techniques. By use of Pressure injector different phases i,e corticomedullay, nephrographic and excretory phases can be exactly acquired with specific time delays. There is optimum load of patients to our hospital from different regions of Andhra Pradesh,with different clinical conditions. The study was done to enlighten high sensitivity and specificity of the MDCT in differentiation of malignant from benign renal masses.
MATERIAL AND METHODS
Clinically suspected patients who were diagnosed to have renal mass on ultrasonography attending Narayana Medical College and Hospital, Nellore. A prospective study was conducted over a period of two years (September 2012 to September 2014) on 40 patients with clinically suspected Renal mass or patients who were diagnosed to have renal mass on ultrasound and were referred to CT for further characterisation. Patients were evaluated with Multidetector Computed Tomography (128 slice GE OPTIMA 660). A provisional diagnosis was suggested after the CT examination and these findings were correlated with histopathology or surgical findings as applicable.
Inclusion criteria:
All the patients with clinically suspected renal mass.
Exclusion criteria:
Simple cysts are not included in the study. Extrarenal masses invading the renal parenchyma are excluded from the study.
CT technique
The patient was scanned using 128 slice MDCT GE OPTIMA 660 equipped with pressure injector was used in the study. Patients were kept nil orally 4 hrs prior to the CT scan to avoid complications while administrating contrast medium. Risks of contrast administration were explained to the patient and consent was obtained prior to the contrast study. The pathological lesions were evaluated with respect to pre and post contrast attenuation values, size, location of the mass, presence of calcification, presence of fat and extension into the adjoining structures. Cases were followed up clinically, histopathologically and radiologically as indicated. The radiological diagnosis was correlated with surgical and histopathological findings.
STATISTICAL ANALYSIS
Data analysis done using ratios, averages of different diagnosis. Outcome of sensitivity, specificity, positive predictive value and negative predictive values are computed and compiled.
RESULTS
Hospital based prospective study, to find the efficiency of computed tomography (plain and contrast) in evaluation and characterisation of renal masses. In our study, the maximum percentage of patients were in the age range of 60-69 years (37.5%) followed by 50 to 59 years (22.5%). There was a male preponderance (65%) when compared to females (35%). Age distribution of the individual pathologies Renal cell carcinoma was diagnosed in 24 (60%) out of 40 patients. 12 (50%) out of 24 patients (60%) were in the age range of 60 -69 years, the youngest patient with RCC was 39 y old male patient and the oldest was 71 years old male patient. The mean age was 61.5 years. Metastasis from the breast and gastrointestinal tract are diagnosed in 2 (5%) out of 40 patients. one in the range of 60-69 y and another in the range of 70-79 y. Transistional cell carcinoma was diagnosed in 1 (2.5%) out of 40 patients, was in the range of 60-69 y. Wilms tumour was diagnosed in 1 (2.5%) out of 40 patients, was in the range of 0-9 years. Angiomyolipomas were diagnosed in 2 (5% 
Diagnosis

MDCT attenuation values
In our study the benign renal masses had an attenuation value of 20.25 HU on precontrast scans, whereas the malignant renal masses showed a higher attenuation value of 28.21 HU. Mean attenuation value of benign renal masses in corticomedullary phase was 30.41 HU and that of malignant masses was 61.78 HU. Mean attenuation value of benign renal masses in Nephrographic phase was 43.08 HU and that of malignant masses was 82.46 HU. Benign renal masses showed an mean increase of 7.1666 HU in the corticomedullary phase, whereas malignant renal masses showed an significant increase of 33.6538 H U. Benign renal masses showed an mean increase of 20.8333 HU in the nephrographic phase, whereas malignant renal masses showed increase of 54.2500 HU. In this work, there was 100% sensitivity, 85.71% specificity, 92.85% positive predictive value, and 100% negative predictive value for final diagnosis of renal mases (table-2).
DISCUSSION
In our study, out of total 40 cases studied, 26 were males and 14 were females (age range from 5 to 73 years), there were 28 (70%) malignant and 12 (30%) benign renal masses. Renal cell carcinoma (n:24) accounted for 60% of all renal masses and 85% of malignant renal masses. The other lesions include Transitional cell carcinoma (n:1), Wilm's tumour (n:01), Metastases (n:2), Angiomyolipoma (n:2), Oncocytoma (n:1), Complex cysts (n:03), Abscess (n=4) and Focal pyelonephritis (n:2). In our study, the maximum percentage of patients were in the age range of 60 to 69 years (37.5%). Out of 40 cases, 28 were diagnosed to be malignant (70%) and 12 cases were diagnosed benign (30%). The most common renal mass was renal cell carcinoma accounting for 60% of all the renal masses and 85% of the malignant renal masses.12 out of 24 patients (50%) of renal cell carcinomas were in the age range of 60 -69 years, the youngest patient with RCC was 39 y old male patient and the oldest was 71 years old male patient. The mean age was 61.5 y. In our study out of 24 cases of RCC 12(50%) were in the range of 60-69 years, 7 (29.16%) in the range of 50-59 years, 3 (12.5%) in the range of 40-49 years, 1 (4.17%) case each in the range of 30-39 years. and 70-79 years. Verhoest G et al 6 in their study have found that the incidence of renal cell carcinoma was 6% in < 40 years, 38.5% in 40-60 years, 52.3% in 60-80 years and 3.2% in > 80 years. Our findings were comparable to the study of Verhoest G et al where the maximum percentage of patients were seen in 60-69 years. In our study out of 40 cases, one (2.5%) case of wilms tumor was noted was the age of 5 years old female patient. Our findings were comparable with the findings of Lonergan et al 7 who have described that the peak incidence of wilms tumor is at 3-4 years and 80% of cases are below 5 years of age.
There was male preponderance (66.66%) in case of RCC when compared to females (33.4%). Male: female ratio is 2.25:1. One case of wilms tumor (100%) was in females. One case of TCC (100%) was in males.2 cases of metastases was equally distributed in males (50%) and females (50%). One case of oncocytoma (100%) was in males. 2 out of 2 (100%) cases of angiomyolipoma were found in females. There was male preponderance (66.66%) in case of complex cyst when compared to females (33.4%). Abscess and focal pyelonephritis are distributed equally in males (50%) and females (50%). Verhoest g et al 6 described the distribution of renal cell cancer with respect to age and gender, in their study too there was predominance of male patients in renal cell carcinoma. In our study, calcification was seen in 7 out of 24 cases of RCCv (29.16%). When compared to benign renal masses malignant renal masses showed more amount of necrosis (54.16% in RCC and 100% in wilms tumour). Renal vein invasion was seen in 5 (20.8%) cases, whereas none of the benign renal masses showed renal vein invasion. Inferior vena caval invasion was seen in 2 (8.33%) out of 24 cases of RCC. Most common site of metastases from renal cell carcinoma was to Lymph nodes (37.5%), Lungs (16.66%), Liver (4.16%) and appendicular skeleton (4.16%).Involvement of Renal vein, adrenals, lungs and appendicular skeleton was not seen in benign masses. The involvement of renal vein, inferior vena cava,adrenals,lymph nodes, liver and appendicular skeleton was seen only in malignant renal masses. Central fibrous scar was seen in oncocytoma (100%). Hemorrhage was seen predominantly in complex cysts (66.66%) followed by angiomyolipomas (50%), RCC (8.3%), metastasis (50% 
